← Browse by Condition
Medical Condition

hepatocellular carcinoma hcc

Total Trials
7
Recruiting Now
7
Trial Phases
Phase 2, Phase 1, Phase 4
NCT07052253 Phase 2
Recruiting

A Phase II Clinical Study of AK104/AK112 in Combination With TT-00420 Tablet for Advanced HCC.

Enrollment
100 pts
Location
China
Sponsor
Akeso
View Trial →
NCT07077356 Phase 1
Recruiting

Application of mRNA Vaccine in Liver Transplantation for Hepatocellular Carcinoma

Enrollment
15 pts
Location
China
Sponsor
West China Hospital
View Trial →
NCT06664996 Phase 2
Recruiting

Sintilimab Combined SBRT As Neoadjuvant Therapy for Resectable HCC with PVTT

Enrollment
33 pts
Location
China
Sponsor
West China Hospital
View Trial →
NCT06653062
Recruiting

Circulating Tumor Mitochondrial DNA (ct-mtDNA) As a Biomarker for Hepatocellular Carcinoma Recurrence Surveillance

Enrollment
50 pts
Location
China
Sponsor
Tongji Hospital
View Trial →
NCT06876753
Recruiting

Regional Lymph Node Metastasis and Survival Outcomes in Advanced HCC

Enrollment
300 pts
Location
China
Sponsor
Zhongda Hospital
View Trial →
NCT07150624 Phase 4
Recruiting

The Treatment of Liver Injury After Liver Resection With Polyene Phosphatidylcholine

Enrollment
96 pts
Location
China
Sponsor
Anhui Provincial Hospital
View Trial →
NCT06999174
Recruiting

Multiparametric MRI for Characterization of Hepatocellular Carcinoma

Enrollment
128 pts
Location
Germany
Sponsor
University Hospital Muenster
View Trial →